The former CFO's sales are substantial in absolute dollar terms but represent a small fraction of the company's market cap. The sales follow restricted stock vesting, which is routine for departing executives. Monitor for any additional insider selling patterns in upcoming Form 4 filings.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $7.87entry
- T+1 · 4d ago −2.67%α −2.31% · $7.66
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Jason A. Clemens, former CFO of AdaptHealth Corp., filed a Form 144 notice to sell 19,855 shares valued at approximately $154,712. The filing also reports two sales executed on November 5 and November 6, 2026, totaling 230,757 shares for about $1.71 million. The Form 144 was filed on November 12, 2026, due to the EDGAR system being closed on November 11 for a federal holiday.
Key Facts
- Jason A. Clemens, former CFO, filed Form 144 to sell 19,855 shares (~$154,712).
- The filing also reports two prior sales: 60,978 shares on Nov 5 and 169,779 shares on Nov 6, 2026, totaling ~$1.71 million.
- All shares were acquired via restricted stock vesting under a registered plan from 2022 and 2023.
- The Form 144 was filed on Nov 12, 2026, because EDGAR was not accepting filings on Nov 11 (federal holiday).
- The proposed sale date for the 19,855 shares is listed as November 11, 2026.
Financial Impact
Total proposed and executed sales of ~250,612 shares, representing about 0.18% of shares outstanding (based on $1.1B market cap and ~$7.79/share price).
Risk Factors
- Insider selling by a former CFO could signal lack of confidence, though the sales are tied to vested restricted stock.
- The filing does not disclose the insider's remaining holdings, making it impossible to assess the proportion sold.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-011009 |
| Document: 0001950047-26-011009-index.html | 0001950047-26-011009 |
| Document: 0001950047-26-011009.txt | 0001950047-26-011009 |
Track record
20 reports on AHCO
6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +47.49% at T+60 after the Jul 2, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $7.80 Now $7.73 −0.90% settles Nov 18
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $7.89 Now $7.73 −2.03% settles Nov 17
- Nov 12, 20264d ago 144 Neutral 3/10 Viewing Entry $7.87 to $7.66 Now $7.73 −1.78% ▼ −2.67% −2.31% vs SPY
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $7.35 to $7.72 Now $7.73 +5.17% ▲ +5.03% +5.40% vs SPY
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $7.35 to $7.72 Now $7.73 +5.17% ▲ +5.03% +5.40% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $7.33 to $7.35 Now $7.73 +5.46% ▲ +0.27% −2.09% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $7.41 to $7.33 Now $7.73 +4.32% ▼ −1.08% −1.39% vs SPY
- Nov 3, 202613d ago 8-K Mixed 6/10 Entry $6.28 to $7.31 Now $7.73 +23.09% ▲ +16.40% +14.75% vs SPY
- Oct 29, 202619d ago Court Ruling Neutral 2/10 Entry $5.81 to $5.91 Now $7.73 +33.05% ▲ +1.72% +2.20% vs SPY
- Oct 13, 20264w ago SC 13G/A Bearish 4/10 Entry $6.33 to $6.25 Now $7.73 −22.12% ▲ +1.26% +0.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers